Earum Pharmaceuticals Q3FY22 net profit slides QoQ to Rs. 95.34 lakhs

has reported Standalone financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 4.8869 crores during the period ended December 31, 2021 as compared to Rs. 10.6233 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 0.9534 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 5.3997 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.15 for the period ended December 31, 2021 as compared to Rs. 0.876 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 4.8869 crs	₹10.6233 crs	-54.00%
Net Profit	₹0.9534 crs	₹5.3997 crs	-82.34%
EPS	₹0.15	₹0.876	-82.88%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 4.8869 crores during the period ended December 31, 2021 as compared to Rs.6.0996 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.0.9534 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-0.3322 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.15 for the period ended December 31, 2021 as compared to Rs.-0.108 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 4.8869 crs	₹6.0996 crs	-19.88%
Net Profit	₹0.9534 crs	₹-0.3322 crs	387.00%
EPS	₹0.15	₹-0.108	238.89%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.18.5799 crores during the 9 Months period ended December 31, 2021 as compared to Rs.48.0268 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.2.94 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-1.8516 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.0.48 for the 9 Months period ended December 31, 2021 as compared to Rs.-0.60 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹18.5799 crs	₹48.0268 crs	-61.31%
Net Profit	₹2.94 crs	₹-1.8516 crs	258.78%
EPS	₹0.48	₹-0.60	180.00%

Source : Equity Bulls

Keywords

EarumPharmaceuticals Q3FY22 9MFY22 ResultUpdate